These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7086324)

  • 21. Evidence of vasopressin in adenohypophysis: research into its role in corticotrope activity.
    Chateau M; Marchetti J; Burlet A; Boulange M
    Neuroendocrinology; 1979; 28(1):25-35. PubMed ID: 431770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies to arginine vasopressin receptor bind to liver, kidney and pituitary membranes.
    Trinder D; Mooser V; Phillips PA; Smith AI; Casley D; Johnston CI
    Clin Exp Pharmacol Physiol; 1993 Jun; 20(6):443-9. PubMed ID: 8339468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine vasopressin as an intragonadal hormone in Brattleboro rats: presence of a testicular vasopressin-like peptide and functional vasopressin receptors.
    Kasson BG; Hsueh AJ
    Endocrinology; 1986 Jan; 118(1):23-31. PubMed ID: 3000735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxytocin receptors in rat adenohypophysis: evidence from radioligand binding studies.
    Antoni FA
    Endocrinology; 1986 Nov; 119(5):2393-5. PubMed ID: 3021442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasopressin activation of phosphatidylinositol metabolism in rat anterior pituitary in vitro and its modification by changes in the hypothalamo-pituitary-adrenal axis.
    Todd K; Lightman SL
    Neuroendocrinology; 1987 Mar; 45(3):212-8. PubMed ID: 3561697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of atrial natriuretic peptides on metabolism of arginine vasopressin by isolated perfused rat kidney.
    Lebowitz MR; Moses AM; Scheinman SJ
    Am J Physiol; 1992 Aug; 263(2 Pt 2):R273-8. PubMed ID: 1387294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial natriuretic factor inhibits the stimulated in-vivo and in-vitro release of vasopressin and oxytocin in the rat.
    Poole CJ; Carter DA; Vallejo M; Lightman SL
    J Endocrinol; 1987 Jan; 112(1):97-102. PubMed ID: 2950195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The vasopressin receptor system in the neonatal pituitary gland: evidence for reduced binding capacity and signal transmission.
    Koch B; Lutz-Bucher B
    Neuroendocrinology; 1990 May; 51(5):592-8. PubMed ID: 2162016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity of vasopressin binding to the posterior pituitary gland in the rat. An autoradiographic study.
    Dashwood MR; Robinson IC
    Neuroendocrinology; 1988 Aug; 48(2):180-7. PubMed ID: 2851751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of specific receptors for vasopressin in the pituitary gland.
    Lutz-Bucher B; Koch B
    Biochem Biophys Res Commun; 1983 Sep; 115(2):492-8. PubMed ID: 6312981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the blood-brain barrier to peptides: accumulation of labelled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions.
    Ermisch A; Barth T; Rühle HJ; Skopková J; Hrbas P; Landgraf R
    Endocrinol Exp; 1985 Mar; 19(1):29-37. PubMed ID: 3872788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunocytochemical localization of vasopressin at its absorption by cells of rat small intestine].
    Selivestrova EV; Shakhmatova EI; Komissarchik IaIu; Prutskova NP; Snigirevskaia ES; Natochin IuV
    Tsitologiia; 2004; 46(11):953-9. PubMed ID: 15704875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arginine-vasopressin binding sites in rat brain: a quantitative autoradiographic study.
    Biegon A; Terlou M; Voorhuis TD; de Kloet ER
    Neurosci Lett; 1984 Feb; 44(3):229-34. PubMed ID: 6728291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood.
    Gibbs DM; Vale W
    Brain Res; 1983 Nov; 280(1):176-9. PubMed ID: 6317143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iodination of vasopressin analogues with agonistic and antagonistic properties: effects on biological properties and affinity for vascular and renal vasopressin receptors.
    Jard S; Lombard C; Seyer R; Aumelas A; Manning M; Sawyer WH
    Mol Pharmacol; 1987 Sep; 32(3):369-75. PubMed ID: 2959851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Identification of specific vasopressin binding sites in cell membranes of the adenohypophysis, liver, kidney and adrenal glands of the rat].
    Korneev AIa; Bragin EO
    Biull Eksp Biol Med; 1989 Oct; 108(10):461-4. PubMed ID: 2532044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anterior pituitary cells from Brattleboro (di/di), Long-Evans and Sprague-Dawley rats contain immunoreactive arginine vasopressin.
    Lolait SJ; Markwick AJ; McNally M; Abraham J; Smith AI; Funder JW
    Neuroendocrinology; 1986; 43(5):577-83. PubMed ID: 3528899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro degradation of some arginine-vasopressin analogs by homogenates of rat kidney, liver and serum.
    Grzonka Z; Kasprzykowski F; Lubkowska L; Darłak K; Hahn TA; Spatola AF
    Pept Res; 1991; 4(5):270-4. PubMed ID: 1802238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone treatment restores reduced vasopressin-binding sites in the kidney of the ageing rat.
    Herzberg NH; Goudsmit E; Kruisbrink J; Boer GJ
    J Endocrinol; 1989 Oct; 123(1):59-63. PubMed ID: 2809490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dopamine on renal receptors for arginine vasopressin.
    Mitsui T; Ogura T; Ota Z; Ogawa N
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):131-41. PubMed ID: 1604042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.